ELI LILLY AND COMPAN

LLY

Delayed - 07/01 04:03:17 pm
324.71USD	+0.15%

Turn to zoom

Prev.	324.7100
Open	323.8800
High	325.4000
Low	317.7600
Volume	1 817 810

2d ago	Pharmaceutical companies still have the upper hand
4d ago	Global markets live: Novartis, Tesla, Disney, Sony, Walmart...
4d ago	Eli Lilly and Company to Supply an Additional 150,000 Doses of...
4d ago	Confidence is key

	Short Term	Mid-Term	Long Term
Trend	Bullish	Bullish	Bullish
Resistance	327	327	326
Spread/Res.	-0,78%	-0,78%	-0,28%
Spread/Supp.	6,1%	13%	16%
Support	306	286	279

Sales 2022	29 054 M - -
Net income 2022	6 999 M - -
Net Debt 2022	9 508 M - -
P/E ratio 2022	42,8x
Yield 2022	1,17%

Capitalization	292 B 292 B -
EV / Sales 2022	10,4x
EV / Sales 2023	9,84x
Nbr of Employees	35 000
Free-Float	99,8%

Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (46.6%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (20.3%);
- immunology diseases (11.8%);
- neurology (6.7%):...

Sector :

Other Pharmaceuticals

Calendar :

2022-08-04 Earnings Release

Trading Rating :

Investor Rating :

Sell Buy
Mean consensus	OUTPERFORM
Number of Analysts	24
Last Close Price	324,71 $
Average target price	316,41 $
Spread / Average Target	-2,56%